Medicine Stock

The Medicine Stocks Package is designed for investors and analysts who need predictions for the best stocks to buy in the Medicine Industry. It includes 20 stocks with bullish and bearish signals and indicates the best medicine stocks to trade:

• Top 10 Medicine stocks for the long position
• Top 10 Medicine stocks for the short position

Package Name: Medicine Stocks
Recommended Positions: Long
Forecast Length: 1 Month (06/23/2017 – 07/23/2017)
I Know First Average: 8.90%

This Medicine Stocks Package forecast had correctly predicted 6 out of 10 stock movements. The top performing prediction from this package was FOLD with a return of 34.09%. SRPT, and VRTX had notable returns of 22.35% and 20.39%. The package’s overall average return was 8.90%, providing investors with a 7.34% premium over the S&P 500’s return of 1.56% during the same period.

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of medicines for various rare and orphan diseases. Its principal product is the migalastat HCl, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease, which has completed two global Phase III registration studies.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.